Researchers at the Cancer Institute, University College London, are using INTEGRA’s unique electronic pipette range to simplify their workflows.Yvette Hoade, a research technician in the Payne Laboratory, Department of Haematology, is investigating mutations associated with various blood diseases such as bone marrow failure and myelodysplastic syndrome (MDS), both age-related disorders that greatly increase the risk of developing leukemia...
Merck, a leading science and technology company, and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. With patients enrolled for clinical trials for this vaccine, rapid development of the large-scale manufacturing process is a critical step in quickly and safely delivering it from the lab to patients....
Beaumont Health’s Research Institute is launching America’s largest serological testing study to help answer many questions surrounding the spread of COVID-19 and potentially help treat patients battling the virus. New study aims to determine the total population with COVID-19 antibodies across a health system, identify potential convalescent plasma donors, better understand disease transmission and contribute to a scientifically-based methodology for returning people to work....
ELISAs (enzyme-linked immunosorbent assays) are popular plate-based methods to detect and quantify peptides, proteins, antibodies or hormones. However, they generally involve multiple pipetting steps that are time-consuming and tedious to perform, requiring consistent processing to ensure success. INTEGRA Biosciences offers a range of liquid handling solutions to improve ELISA workflows...
LGC has launched a Proficiency Testing (PT) service for the detection of SARS-CoV-2 (COVID 19) by nucleic acid amplification testing, one of the first global schemes for COVID-19. As increasing numbers of diagnostic methods are made available in the global fight against COVID 19, it is essential that laboratories ensure that their application of methods and subsequent results are reliable and accurate...
Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced it is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits. The goal of this validation study is to evaluate the efficacy of the new at-home test for diagnosing COVID-19....
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), continues the 2020 LIMS Webcast series on Wednesday, April 15th with Getting More from Your LIMS and Knowing When It's Time to Upgrade. This webcast will be ideal for laboratories who currently are using a LIMS but realize that changes in business requirements, regulatory compliance...
The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19....
Electronic laboratory notebook (ELN) pioneer, BioData, announces its support for the global science community with the introduction of a new video conferencing service in its leading Labguru ELN platform, free of charge for all customers. The new LabRoom tool facilitates live global collaboration, experiment planning and tracking, as well as data collation and analysis, all within the Labguru electronic web notebook...
The University of Glasgow will host a major COVID-19 testing facility in Glasgow, in support of current UK and Scottish Governments and NHS efforts against the coronavirus pandemic. This is part of a series of measures to increase testing and response to the spread of COVID-19 across the UK. It will be opened in collaboration with the Scottish Government and industry experts from BioAscent Discovery Ltd and the University of Dundee’s Drug Discovery Unit....
Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing....
Britain could be testing up to 100,000 patients per day for COVID-19 and have results back within 24 hours – if many researchers who are currently sitting at home were classed as key workers and redundant taxi drivers and delivery companies enlisted. hat is the view of infectious disease expert Professor Colin Garner who has written to Prime Minister Boris Johnson to ask why we are creating “a central testing facility in Milton Keynes”...
In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators....
Olympus is proud to announce the winners of its first Global Image of the Year Life Science Light Microscopy Award, a competition that recognizes the best in life science imaging worldwide. Ainara Pintor from Spain was selected as the global winner for her vibrant image of an immunostained mouse brain slice with two fluorophores. She named her winning image “Neurogarden” because it reflects the brain’s complexity....
Collaboration to initially focus on the development and global commercialisation of a suite of CelLuminate dyes, specifically created to revolutionise live cell imaging by enabling cells to remain functional and viable for up to 14 days. Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut® Technology, have announced a partnership to commercialise the cell delivery potential of...
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials....
Castor, a health-tech company that enables medical researchers to capture machine readable data to optimize medical decision making, announced the launch of its global COVID-19 monitoring and research platform to facilitate the rapid deployment of trials to test Coronavirus vaccines and COVID-19 treatments. After offering free access to their platform for all COVID-19 research projects...
The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels. This extreme influx of samples quickly exhausted the capacity of existing systems in the Microbiology and Molecular Pathology Department at Sullivan Nicolaides Pathology (SNP) – part of the Sonic Healthcare Group – in Brisbane, Australia, creating a clear need for additional automated liquid handling instruments....
The Francis Crick Institute, the UK’s largest discovery biomedical research lab, has offered to support the Government’s efforts to tackle the spread of COVID-19. In communications with Government Chief Scientific Adviser, Sir Patrick Vallance, the Crick’s extensive scientific resources and expertise have been offered to assist in the Government’s fight against the Coronavirus pandemic by helping to increase the number of tests that can be conducted by Public Health England and the NHS....
Test will now be available for qualified laboratories across the European Union. Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19. "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
3-Monochloropropane-1,2-diol (3-MCPD), 2-monochloropropane-1,3-diol (2-MCPD) and glycidol are known as contaminants in foodstuffs due to manufacturing. MCPD fatty acids may occur during the refinement process of oils and fats at high temperature or in the presence of chloride containing salts. However, refinement is an essential chemical and physical process. Only through this kind of treatment with high temperature undesired odorants and flavoring substances as well as possible traces of toxic compounds (pesticides, heavy metals or mycotoxins)...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens....